Medtecs International Stock Fundamentals
| 9103 Stock | TWD 6.28 0.08 1.29% |
Medtecs International fundamentals help investors to digest information that contributes to Medtecs International's financial success or failures. It also enables traders to predict the movement of Medtecs Stock. The fundamental analysis module provides a way to measure Medtecs International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtecs International stock.
Medtecs |
Medtecs International Company Current Valuation Analysis
Medtecs International's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medtecs International Current Valuation | 1.58 B |
Most of Medtecs International's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtecs International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medtecs International has a Current Valuation of 1.58 B. This is 89.03% lower than that of the Healthcare sector and 87.31% lower than that of the Medical Devices industry. The current valuation for all Taiwan stocks is 90.52% higher than that of the company.
Medtecs International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medtecs International's current stock value. Our valuation model uses many indicators to compare Medtecs International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtecs International competition to find correlations between indicators driving Medtecs International's intrinsic value. More Info.Medtecs International is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medtecs International's earnings, one of the primary drivers of an investment's value. Medtecs International is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is presently estimated at about 2.62 Billion. Medtecs International totals roughly 1.58 Billion in current valuation claiming about 60% of all equities under Medical Devices industry.Medtecs Fundamentals
| Return On Equity | -0.0322 | |||
| Return On Asset | -0.0239 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 1.58 B | |||
| Shares Outstanding | 544.91 M | |||
| Price To Earning | 515.00 X | |||
| Price To Book | 5.23 X | |||
| Price To Sales | 45.54 X | |||
| Revenue | 144.16 M | |||
| Gross Profit | 43.48 M | |||
| EBITDA | 24.4 M | |||
| Net Income | 17.34 M | |||
| Cash And Equivalents | 8.21 M | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 64.40 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 29.76 M | |||
| Earnings Per Share | 0.93 X | |||
| Number Of Employees | 15 | |||
| Beta | 1.31 | |||
| Market Capitalization | 3.9 B | |||
| Total Asset | 215.57 M | |||
| Retained Earnings | 25 M | |||
| Working Capital | 18 M | |||
| Current Asset | 64 M | |||
| Current Liabilities | 46 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 215.57 M | |||
| Last Dividend Paid | 0.006 |
About Medtecs International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtecs International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtecs International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtecs International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medtecs International Corporation Limited, an integrated healthcare products and services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups worldwide. The company was founded in 1989 and is headquartered in Taipei City, Taiwan. MEDTECS INTERNATIONAL operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medtecs Stock Analysis
When running Medtecs International's price analysis, check to measure Medtecs International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtecs International is operating at the current time. Most of Medtecs International's value examination focuses on studying past and present price action to predict the probability of Medtecs International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtecs International's price. Additionally, you may evaluate how the addition of Medtecs International to your portfolios can decrease your overall portfolio volatility.